ClinicalTrials.Veeva

Menu

Safety and Efficacy Study of AI Wall Thickness Measurement (EchoNet-LVH-RCT)

Cedars-Sinai Medical Center logo

Cedars-Sinai Medical Center

Status

Not yet enrolling

Conditions

Heart Failure

Treatments

Diagnostic Test: AI Evaluation
Diagnostic Test: Sonographer Evaluation

Study type

Interventional

Funder types

Other

Identifiers

NCT05791227
STUDY00002521

Details and patient eligibility

About

To determine whether an integrated AI decision support can save time and improve accuracy of assessment of echocardiograms, the investigators are conducting a blinded, randomized controlled study of AI guided measurements of wall thickness in parasternal long axis view compared to sonographer measurements in preliminary readings of echocardiograms.

Enrollment

4,000 estimated patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Sonographers and cardiologists at CSMC Echocardiography Lab
  • All transthoracic echocardiogram studies performed in the CSMC echocardiogram lab

Exclusion criteria

  • transthoracic echocardiogram studies not able to be measured by sonographers in run in period

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

4,000 participants in 2 patient groups

Sonographer Annotation
Active Comparator group
Description:
Currently, sonographer technicians provide preliminary interpretations prior to validation and overreading by cardiologists. This staggered, stepwise evaluation allows for the introduction of AI decision support with minimal impact on patient care. Physicians are already used to adjusting the preliminary report given the variable training of sonographers and on the lookout for changes, variation, or adjustments that need to be made.
Treatment:
Diagnostic Test: Sonographer Evaluation
Artificial Intelligence Annotation
Experimental group
Description:
A novel AI algorithm developed to assess measurements of left ventricular diameter during diastole (LVIDd), intraventricular septum thickness during diastole (IVSd) and left ventricular posterior wall thickness during diastole (LVPWd). The AI will provide preliminary assessments for cardiologist evaluation.
Treatment:
Diagnostic Test: AI Evaluation

Trial contacts and locations

0

Loading...

Central trial contact

David Ouyang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems